Windlas Biotech concludes European Union GMP Inspection

16 Apr 2022 Evaluate

Windlas Biotech has concluded its European Union GMP Inspection carried out by National Institute of Pharmacy and Nutrition, Hungary for the Plant-IV situated at Dehradun with zero critical observations. The company had undergone this inspection from April 11 to 13, 2022.

Windlas Biotech is into domestic pharmaceutical formulations contract development and manufacturing business.

Windlas Biotech Share Price

743.40 -15.10 (-1.99%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×